105 related articles for article (PubMed ID: 25597344)
21. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
[TBL] [Abstract][Full Text] [Related]
22. Association between Parathyroid Hormone and Cardiovascular Disease.
Fujii H
Ther Apher Dial; 2018 Jun; 22(3):236-241. PubMed ID: 29707916
[TBL] [Abstract][Full Text] [Related]
23. 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism.
Drezner MK; Neelon FA; Haussler M; McPherson HT; Lebovitz HE
J Clin Endocrinol Metab; 1976 Apr; 42(4):621-8. PubMed ID: 1083395
[TBL] [Abstract][Full Text] [Related]
24. Function of parathyroid glands in kidney transplant patients--diagnostic value of CAP and CIP.
Spiechowicz U; Kokot F; Wiecek A
Ann Transplant; 2004; 9(3):33-6. PubMed ID: 15759544
[TBL] [Abstract][Full Text] [Related]
25. Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease.
Fidan N; Inci A; Coban M; Ulman C; Kursat S
J Investig Med; 2016 Apr; 64(4):861-6. PubMed ID: 26969749
[TBL] [Abstract][Full Text] [Related]
26. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
[TBL] [Abstract][Full Text] [Related]
27. The importance of bone biomarkers in the diagnosis of renal osteodystrophy.
Pena YT; Soyibo AK; McGrowder D; Clarke TR; Barton EN
West Indian Med J; 2010 Jun; 59(3):332-7. PubMed ID: 21291118
[TBL] [Abstract][Full Text] [Related]
28. Vitamin K₂ alters bone metabolism markers in hemodialysis patients with a low serum parathyroid hormone level.
Ochiai M; Nakashima A; Takasugi N; Kiribayashi K; Kawai T; Usui K; Shigemoto K; Hamaguchi N; Kohno N; Yorioka N
Nephron Clin Pract; 2011; 117(1):c15-9. PubMed ID: 20689320
[TBL] [Abstract][Full Text] [Related]
29. PTH--a particularly tricky hormone: why measure it at all in kidney patients?
Garrett G; Sardiwal S; Lamb EJ; Goldsmith DJ
Clin J Am Soc Nephrol; 2013 Feb; 8(2):299-312. PubMed ID: 22403273
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Intact Parathyroid Hormone, Alkaline Phosphatase, Phosphate Levels for Diagnosing Severe Metabolic Bone Disease in Infants with Severe Bronchopulmonary Dysplasia.
Tkach EK; White AM; Dysart KC; Waber B; Nawab US; Zhang H; Jensen EA
Am J Perinatol; 2017 Oct; 34(12):1199-1204. PubMed ID: 28431438
[No Abstract] [Full Text] [Related]
31. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
Ziółkowska H; Roszkowska-Blaim M
Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516
[TBL] [Abstract][Full Text] [Related]
32. Parathyroid hormone measurement in CKD.
Souberbielle JC; Roth H; Fouque DP
Kidney Int; 2010 Jan; 77(2):93-100. PubMed ID: 19812537
[TBL] [Abstract][Full Text] [Related]
33. Effect of raloxifene on parathyroid hormone in osteopenic and osteoporotic postmenopausal women with chronic kidney disease stage 5.
Haghverdi F; Farbodara T; Mortaji S; Soltani P; Saidi N
Iran J Kidney Dis; 2014 Nov; 8(6):461-6. PubMed ID: 25362221
[TBL] [Abstract][Full Text] [Related]
34. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure].
Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M
Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939
[TBL] [Abstract][Full Text] [Related]
35. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients.
Soohoo M; Feng M; Obi Y; Streja E; Rhee CM; Lau WL; Wang J; Ravel VA; Brunelli S; Kovesdy CP; Kalantar-Zadeh K
Am J Nephrol; 2016; 43(2):85-96. PubMed ID: 26950688
[TBL] [Abstract][Full Text] [Related]
36. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
[TBL] [Abstract][Full Text] [Related]
37. Characterization of serum alkaline phosphatase of hepatobiliary and osteoblastic origin.
Forman DT; Zeiss CR; Etheridge CL; Grayson SH
Ann Clin Lab Sci; 1973; 3(3):201-6. PubMed ID: 4703527
[No Abstract] [Full Text] [Related]
38. Association between indoxyl sulfate and skeletal resistance in hemodialysis patients.
Goto S; Fujii H; Hamada Y; Yoshiya K; Fukagawa M
Ther Apher Dial; 2010 Aug; 14(4):417-23. PubMed ID: 20649763
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the Elecsys PTH(1-84) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients.
Tan K; Ong L; Sethi SK; Saw S
Clin Biochem; 2013 Jun; 46(9):781-6. PubMed ID: 23384535
[TBL] [Abstract][Full Text] [Related]
40. Positive correlation of serum bio-intact PTH(1-84) but not intact PTH with parathyroid gland size in hemodialysis patients.
Inaba M; Okuno S; Chou H; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y
Biomed Pharmacother; 2006 Feb; 60(2):62-5. PubMed ID: 16460905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
